Hedeker Wealth, LLC Vertex Pharmaceuticals Inc Transaction History

Hedeker Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$181.39 - $202.99 $1.58 Million - $1.77 Million	-8,717 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$187.49 - $221.1 $22,873 - $26,974	122 Added 1.42%	8,717 $1.76 Million
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $41,818 - $48,744	202 Added 2.41%	8,595 $1.85 Million
Q4 2020 Jan 19, 2021	BUY	$207.01 - $276.09 $146,149 - $194,919	706 Added 9.18%	8,393 $1.98 Million
Q3 2020 Oct 26, 2020	BUY	$255.65 - $303.1 $1.97 Million - $2.33 Million	7,687 New	7,687 $2.09 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Hedeker Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Hedeker Wealth, LLC with notifications on news.